REDHILL BIOPHARMA LTD. Increase Decrease Through Exercise Of Options
REDHILL BIOPHARMA LTD. (RDHL) reported Increase Decrease Through Exercise Of Options of $4.01 million for the 12-month period ending 2021-12-31, per its 20-F filed 2024-04-08.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions · last filed 2024-04-08
- REDHILL BIOPHARMA LTD. increase decrease through exercise of options for the quarter ending 2021-06-30 was $114.00K.
| Period end | Increase Decrease Through Exercise Of Options 3 month | Increase Decrease Through Exercise Of Options 6 month | Increase Decrease Through Exercise Of Options 12 month |
|---|---|---|---|
| 2021-12-31 | $4.01M 20-F · filed 2024-04-08 | ||
| 2021-06-30 | $114.00K 6-K · filed 2022-11-07 | $3.34M 6-K · filed 2022-11-07 | |
| 2020-12-31 | $52.00K 20-F · filed 2023-04-28 | ||
| 2019-12-31 | $5.00K 20-F · filed 2022-03-17 | ||
| 2018-12-31 | $361.00K 20-F · filed 2021-03-18 | ||
| 2018-06-30 | $355.00K 6-K · filed 2019-07-23 | ||
| 2017-12-31 | $3.46M 20-F · filed 2020-03-04 | ||
| 2017-06-30 | $3.43M 6-K · filed 2018-08-30 | ||
| 2016-12-31 | $263.00K 20-F · filed 2019-02-26 | ||
| 2015-12-31 | $108.00K 20-F · filed 2018-02-22 |